Latest filing published 16 Mar 2018 for Orexigen Therapeutics, Inc., €329.
Stephen A. Moglia is a declared insider of Orexigen Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 19 December 2016 and 15 March 2018, the trades on record add up to 2 filings.
Sales make up the whole of the open-market record (2 sales, €1,829). So far in 2018, the count stands at no purchases and 1 sale.
The record was last updated on 16 March 2018 with an open-market sale (€329) in Orexigen Therapeutics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations